1. Academic Validation
  2. Antiviral effect of vesatolimod (GS-9620) against foot-and-mouth disease virus both in vitro and invivo

Antiviral effect of vesatolimod (GS-9620) against foot-and-mouth disease virus both in vitro and invivo

  • Antiviral Res. 2022 Sep;205:105384. doi: 10.1016/j.antiviral.2022.105384.
Gyeongmin Lee 1 Hyo Rin Kang 1 Aro Kim 1 Jong-Hyeon Park 1 Min Ja Lee 1 Su-Mi Kim 2
Affiliations

Affiliations

  • 1 Center for Foot-and-Mouth Disease Vaccine Research, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-City, Gyeongsangbuk-do, Republic of Korea.
  • 2 Center for Foot-and-Mouth Disease Vaccine Research, Animal and Plant Quarantine Agency, 177 Hyeoksin 8-ro, Gimcheon-City, Gyeongsangbuk-do, Republic of Korea. Electronic address: beliefsk@korea.kr.
Abstract

Foot-and-mouth disease (FMD) is an acute contagious disease of cloven-hoofed Animals such as cows, pigs, sheep, and deer. The current emergency FMD vaccines, to induce early protection, have limited use, as their protective effect in pigs does not begin until 7 days after vaccination. Therefore, the use of Antiviral agents would be required for reducing the spread of foot-and-mouth disease virus (FMDV) during outbreaks. Vesatolimod (GS-9620), a Toll-like Receptor 7 agonist, is an Antiviral agent against various human disease-causing viruses. However, its Antiviral effect against FMDV has not been reported yet. The aim of this study was to investigate the Antiviral effects of GS-9620 against FMDV both in vitro and in vivo. The inhibitory effect of GS-9620 on FMDV in swine cells involved the induction of porcine interferon (IFN)-α and upregulation of interferon-simulated genes. Protective effect in mice injected with GS-9620 against FMDV was maintained for 5 days after injection, and cytokines such as IFN-γ, interleukin (IL)-12, IL-6, and IFN-γ inducible protein-10 could be detected following the treatment with GS-9620. Furthermore, the combination of GS-9620 with an FMD-inactivated vaccine was found to be highly effective for early protection in mice. Overall, we suggest GS-9620 as a novel and effective Antiviral agent for controlling FMDV Infection.

Keywords

Antiviral effect; Cytokines; Foot-and-mouth disease virus; GS-9620.

Figures
Products